Medical device development company Evolve Medtech Partners announced on Wednesday that Rob Abrams has joined the company's team.
With more than 30 years of experience in biomedical device product development, research, operational management, new business development and strategic investments, Abrams currently serves as a senior global business development and strategy executive with Kaneka Corp.
Abrams previously served as an operating partner at Sanderling Ventures and CEO of Pulsar Vascular, which was acquired by Johnson & Johnson.
Before he joined Sanderling, Abrams was group vice president of new business development for cardiovascular at Boston Scientific and has also served in various roles at Target Therapeutics, Localmed, Howmedica, and Guidant. lve-medtech.com
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon